Polarean Imaging enters promotion deal with Ascend Imaging

(Sharecast News) - Polarean Imaging announced on Tuesday that it has entered into a new commercial agreement with Ascend Imaging to support the promotion and sale of its Xenon MRI technology in selected US states, in a move aimed at accelerating market penetration and expanding access to its functional lung imaging platform.

Under the terms of the non-exclusive agreement, Ascend Imaging would act as an independent manufacturer's representative across four US states.

The AIM-traded firm said Ascend would work alongside its in-house sales team to identify new customer opportunities, build engagement, and support deal execution.

Polarean said the partnership would enhance its regional coverage while preserving operational efficiency, as it seeked to build momentum in the second half of 2025 and beyond.

"We are pleased to welcome Ascend Imaging as a strategic sales partner," said Polarean's vice-president of sales Alan Huang.

"Their focus on radiology and radiation oncology, combined with a deep understanding of imaging workflows and strong customer relationships, aligns well with our commercial strategy.

"This partnership enhances our reach in key US regions while maintaining operational efficiency, and we expect it to support meaningful commercial momentum in the second half of 2025 and beyond."

Ascend Imaging, which focuses on radiology and radiation oncology technologies including advanced imaging and AI-driven tools, brings a network of established healthcare relationships that Polarean expected would complement its commercial efforts.

"We are excited to partner with Polarean to help bring their groundbreaking Xenon MRI technology to more healthcare providers," commented Wesley Adams, president of Ascend Imaging.

"Our experience in radiology and AI solutions, combined with long-standing customer relationships, positions us well to support Polarean's mission of revolutionizing pulmonary medicine."

At 1148 BST, shares in Polarean Imaging were up 1.79% at 1.43p.

Reporting by Josh White for Sharecast.com.